Literature DB >> 19007044

Anti-nociceptive and anti-inflammatory properties of 5alpha-reductase inhibitor finasteride in experimental animals.

N Duborija-Kovacevic1, V Jakovljevic, A Sabo, Z Tomic.   

Abstract

Finasteride is a potent drug which has been prescribed for the management of benign prostatic hyperplasia (BPH) for more than 20 years. Recent studies indicate that finasteride, as 5alpha-reductase inhibitor, can influence some central effects such as analgesia, neurosteroidogeneses and behavior. The purpose of this study was to investigate the analgesic effect of finasteride, to determine whether finasteride interact with morphine analgesia in tail-flick test and to examine the anti-inflammatory effect of this drug. Adult male Wistar rats (280-330 g) were used for the both of experiments. Tests were assessed on groups of 6 animals. The first control group (O) received water (1 ml/kg, p.o.), the second control group (OO) received the vehicle (olive oil, 1 ml/kg, p.o.) and the third group (F) received finasteride (0.5 mg/kg, p.o.) suspended in olive oil, every morning for 30 days. After 30 days of treatment, tail-flick test and formalin-induced foot paw edema test were performed. Finasteride increased the average latency in seconds in comparison to both controls (10.06 vs. 9.16 and 8.66 s). It was 9.83% higher depression of pain in group F in comparison to O and 16.17% in comparison to OO, but the anti-nociceptive effect of finasteride at applied dose didn't significantly differ compared to both controls (p > 0.05). Chronic pre-treatment with finasteride didn't interact with analgesic effect of morphine compared to O (p > 0.05), but compared to OO finasteride fastened, increased and prolonged the analgesic effect of morphine at all measuring intervals, achiving statistical significance in 60 min (p < 0.01). Finasteride also exhibited significant anti-inflammatory action (p < 0.05) in comparison to OO, but It was not significantly different from the control O. Finasteride didn't exert analgesic action, it increased morphine antinociception and showed chronic anti-inflammatory effect to some extent. This might be a useful contribution to highlight the pathogenesis of BPH. There is the need for further studies in order to confirm these results with more details.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19007044     DOI: 10.1007/BF03191116

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  16 in total

1.  Inhibiting progesterone metabolism in the hippocampus of rats in behavioral estrus decreases anxiolytic behaviors and enhances exploratory and antinociceptive behaviors.

Authors:  M E Rhodes; C A Frye
Journal:  Cogn Affect Behav Neurosci       Date:  2001-09       Impact factor: 3.282

Review 2.  Molecular and cellular pathogenesis of benign prostatic hyperplasia.

Authors:  Keith L Lee; Donna M Peehl
Journal:  J Urol       Date:  2004-11       Impact factor: 7.450

Review 3.  Could inflammation be a key component in the progression of benign prostatic hyperplasia?

Authors:  Gero Kramer; Michael Marberger
Journal:  Curr Opin Urol       Date:  2006-01       Impact factor: 2.309

4.  [Finanseride in symtomatic benign prostatic hyeprtrophy. A 2-year placebo-controlled study].

Authors:  J T Andersen; H Wolf; P Ekman; H O Beisland; J E Johansson; M Kontturi; T Lehtonen; K Tveter
Journal:  Ugeskr Laeger       Date:  1996-09-02

5.  In vivo evidence for an increase in 5alpha-reductase activity in the rat central nervous system following morphine exposure.

Authors:  Hossein Amini; Abolhassan Ahmadiani
Journal:  Int J Dev Neurosci       Date:  2005-09-06       Impact factor: 2.457

Review 6.  Benign prostatic hyperplasia: age-related tissue-remodeling.

Authors:  Gerold Untergasser; Stephan Madersbacher; Peter Berger
Journal:  Exp Gerontol       Date:  2005-01-22       Impact factor: 4.032

Review 7.  Immune-to-brain communication dynamically modulates pain: physiological and pathological consequences.

Authors:  Julie Wieseler-Frank; Steven F Maier; Linda R Watkins
Journal:  Brain Behav Immun       Date:  2005-03       Impact factor: 7.217

8.  Antipsychotic-like properties of 5-alpha-reductase inhibitors.

Authors:  Marco Bortolato; Roberto Frau; Marco Orrù; Youri Bourov; Francesco Marrosu; Giampaolo Mereu; Paola Devoto; Gian L Gessa
Journal:  Neuropsychopharmacology       Date:  2008-03-19       Impact factor: 7.853

Review 9.  5 alpha-reductase isozymes in the central nervous system.

Authors:  A Poletti; A Coscarella; P Negri-Cesi; A Colciago; F Celotti; L Martini
Journal:  Steroids       Date:  1998 May-Jun       Impact factor: 2.668

10.  Anatomical and cellular localization of neuroactive 5 alpha/3 alpha-reduced steroid-synthesizing enzymes in the spinal cord.

Authors:  Christine Patte-Mensah; Trevor M Penning; Ayikoe G Mensah-Nyagan
Journal:  J Comp Neurol       Date:  2004-09-20       Impact factor: 3.215

View more
  2 in total

1.  Role of 5α-reductase inhibitors in modulation of the analgesic effects of morphine: an emerging concept in pain management.

Authors:  Shailendra Kapoor
Journal:  Neurol Sci       Date:  2012-03-17       Impact factor: 3.307

2.  Finasteride Has Regionally Different Effects on Brain Oxidative Stress and Acetylcholinesterase Activity in Acute Thioacetamide-Induced Hepatic Encephalopathy in Rats.

Authors:  Dušan Mladenović; Nataša Petronijević; Tihomir Stojković; Milica Velimirović; Gordana Jevtić; Dragan Hrnčić; Tatjana Radosavljević; Aleksandra Rašić-Marković; Nebojša Maksić; Dragan Djuric; Olivera Stanojlović
Journal:  PLoS One       Date:  2015-08-04       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.